News ID: 302560
Published: 0242 GMT April 27, 2021

Russia says Brazil refusal to import Sputnik V 'political'

Russia says Brazil refusal to import Sputnik V 'political'
REUTERS

The developers of Russia's Sputnik V coronavirus vaccine on Tuesday criticized Brazil's refusal to import the jab as politically motivated.

Brazilian health regulator Anvisa on Monday denied requests from several states to receive batches of Sputnik V, saying it did not have the data needed to verify the jab's safety and efficacy, AFP reported.

"Anvisa's delays in approving Sputnik V are unfortunately of a political nature and have nothing to do with access to information or science," the official’s Sputnik V Twitter account said.

It pointed to a recent US government report that said Washington had tried to persuade Brazil not to use Sputnik.

"The United States Department of Health, in its 2020 annual report several months ago, publicly stated that the United States health attache 'persuaded Brazil to reject the Russian vaccine against COVID-19,'" the account added.

Anvisa said its experts had flagged "uncertainties" about the jab, which has not yet been approved by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA).

The Russian vaccine has so far been approved for use in at least 60 countries, including more than 10 in Latin and Central America.

Argentina signed a deal with Russia earlier this month to become the first Latin American country to produce Sputnik V shots, and will aim for full-scale production to start in June.

The Kremlin said Tuesday it needed more information about the Brazilian decision before commenting, adding that it was not in touch with Brazilian authorities on the issue.

But in general, Kremlin spokesman Dmitry Peskov told reporters, "We are against the use of vaccines as a political tool."

Moscow registered the Sputnik V in August before large-scale clinical trials, but leading medical journal The Lancet has since said it is safe and more than 90 percent effective.

 

 

 

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/1900 sec